Ukraine

BMI View: As BMI has previously warned, the Ukrainian government is now getting serious in its plans for greater control of drug prices in the domestic market. However, drug policy... 2012-03-05

BMI View: Three main factors govern our outlook for Ukraine's pharmaceutical market in 2012 and 2013: the worsening economic growth prospects, the high potential for devaluation of... 2012-02-01

BMI View: Sopharma's successful transition from a domestically focused drugmaker to a substantial exporter of pharmaceuticals to Eastern and South Eastern Europe underlines its potential... 2011-12-13

BMI View: The defeat of a bill that would have led to a complete ban on the advertising over-the-counter (OTC) medicines in Ukraine will be welcomed by drug makers operating in the... 2011-11-15

BMI View: Central and Eastern Europe (CEE)'s attractiveness to drugmakers has improved. BMI's Pharmaceuticals and Healthcare Business Environment Ratings (BERs), which assess markets... 2011-10-12

BMI View: Ukraine's medical device market rebounded positively in 2010, with the market projected to return low double-digit growth over BMI's five- and ten-year forecast horizons.... 2011-08-23

BMI View: Our view that Ukraine's pharmaceutical market will continue to return double-digit growth rates into 2011 has been confirmed. In fact, stronger than expected growth rates... 2011-08-02

BMI View: The rapid development of Ukraine's pharmaceutical market has attracted strong interest from multinational drugmakers as a lucrative import destination and we hold our view... 2011-05-17

BMI View: Our view that Ukraine's pharmaceutical market will continue to see strong-double-digit growth into 2011 have now been confirmed. Supported by a return to economic growth,... 2011-05-11

BMI View: The value of the Doktor Mom over-the-counter (OTC) brand is determined not by its current sales or product portfolio, but by the acquirer's ability to exploit the intangible... 2011-05-10